Seremedi One of Two US Companies Chosen for the MEDICA World App Competition November 16 in Germany

Share Article

Houston Digital Health Leader Enables Collaborative Connected Care That Results in Better Patient Outcomes

Seremedi, Inc., the digital health leader and resident company of JLABS @ TMC, is proud today to announce its CareScriptions® patient care platform has been selected as one of the 2016 finalists for the MEDICA World App Competition. Seremedi is one of only two companies selected from the U.S for this competition which is part of MEDICA World, the world’s leading healthcare conference for the medical industry. The competition is focused on identifying the best Medical Mobile Solution intended for use by care teams as they implement new mobile patient care models that provides efficient, effective care across the continuum. Seremedi will present its solution November 16 in Germany.

“CareScriptions is a perfect fit for this category and we are delighted to represent the U.S. with this prestigious honor,” said Kim Bond Evans, CEO of Seremedi. “Patients who have major procedures experience poor outcomes after discharge when their care team has little to no access to data informing them of success of recovery. Poor care coordination that is disconnected causes patients to slip through the cracks, and many get worse, not better, sometimes resulting in death. Historically, patients are discharged and disconnected from the care team, making it difficult for healthcare professionals to intervene when patients experience difficulties. Now, with CareScriptions, all essential elements for effective patient care coordination are integrated for best outcomes.”

CareScriptions is preferred by healthcare organizations for its unique approach to patient care which delights both care team and patient - integrating the essential care capabilities enabling care teams to instantly receive critical patient status information when they want it, how they want it. Communicating with patients is triggered in real-time using a patient’s media of choice -providing them with a convenient, easy to use application that assists recovery. CareScriptions minimizes adverse events, reduces readmission rates, improves efficiency, enhances patient recovery and improves the clinician-patient relationship.

About the MEDICA World App Competition (#5MAC16)
The MEDICA World App competition finalists will be provided the opportunity to present their solutions at the MEDICA Trade Fair, being held in Dusseldorf Germany November 14 – 17. The presentations will take place on November 16 live on stage at the MEDICA Connected Healthcare Forum in Hall 15. More information on the competition can be found at the MEDICA website.

“This is the world's largest competition of this kind,” explains Mark Wächter, organizer of the MEDICA World App Competition. “The organizers are looking for business-oriented solutions that help groups of doctors, hospitals or medical teams with simplifying and streamlining daily caring for patients.” For more, follow Mark at @_mistermobile

About Seremedi
Seremedi is a Houston-based digital health leader and resident company of JLABS @ TMC. Its CareScriptions® integrated mobile patient care platform helps medical professionals improve the perioperative care experience by connecting patients and care teams to deliver critical patient data in real-time, increasing visibility into patient preparation and recovery, and enabling the best recovery outcomes while minimizing avoidable risks and costs. More informed, invested and connected patient-physician teams working together result in better outcomes for the patient, and a decrease in major surgery related complications, readmissions and costs. CareScriptions delivers collaborative connected care supporting the doctor-patient commitment to work together through patient recovery. Seremedi is a leading technology partner in Perioperative Care and proud to present this discussion on Enhanced Recovery and the Perioperative Surgical Home. For more, see or follow @CareScriptions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Laura Beck
+1 (512) 786-1098
Email >

Dana Abramovitz
Visit website